Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Cancers
|
October 30, 2020
Natural Killer Cells in Immunotherapy: Are We Nearly There?
Mireia Bachiller, Anthony M Battram, Lorena Perez-Amill, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology
|
September 7, 2018
CAR-T Cell Therapy: A Door Is Open to Find Innumerable Possibilities of Treatments for Cancer Patients
Lorena Perez-Amill, Berta Marzal, Alvaro Urbano-Ispizua, et al.
International Journal of Molecular Sciences
|
August 30, 2017
Natural Killer Cells: Angels and Devils for Immunotherapy
Beatriz Martín-Antonio, Guillermo Suñe, Lorena Perez-Amill, et al.
Journal for Immunotherapy of Cancer
|
August 26, 2021
NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness
Mireia Bachiller, Lorena Perez-Amill, Anthony Matthew Battram, et al.
Haematologica
|
January 11, 2020
Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma
Lorena Perez-Amill, Guillermo Suñe, Asier Antoñana-Vildosola, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2026
Enhanced antitumoral activity of the academic CAR-T ARI0002h against normal and low BCMA-expressing myeloma cells after incorporating a transmembrane CD28 domain
Oriol Cardus, Joan Mañé Pujol, Anna de Daniel, et al.
Oncoimmunology
|
July 13, 2025
TIGIT blockade in the context of BCMA-CART cell therapy does not augment efficacy in a multiple myeloma mouse model
Aina Oliver-Caldes, Joan Mañe Pujol, Anthony M Battram, et al.
Journal for Immunotherapy of Cancer
|
December 8, 2021
First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma
Aina Oliver-Caldes, Raquel Jiménez, Marta Español-Rego, et al.
Science Translational Medicine
|
February 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo
Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Cancers
|
October 30, 2020
Natural Killer Cells in Immunotherapy: Are We Nearly There?
Mireia Bachiller, Anthony M Battram, Lorena Perez-Amill, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology
|
September 7, 2018
CAR-T Cell Therapy: A Door Is Open to Find Innumerable Possibilities of Treatments for Cancer Patients
Lorena Perez-Amill, Berta Marzal, Alvaro Urbano-Ispizua, et al.
International Journal of Molecular Sciences
|
August 30, 2017
Natural Killer Cells: Angels and Devils for Immunotherapy
Beatriz Martín-Antonio, Guillermo Suñe, Lorena Perez-Amill, et al.
Journal for Immunotherapy of Cancer
|
August 26, 2021
NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness
Mireia Bachiller, Lorena Perez-Amill, Anthony Matthew Battram, et al.
Haematologica
|
January 11, 2020
Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma
Lorena Perez-Amill, Guillermo Suñe, Asier Antoñana-Vildosola, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2026
Enhanced antitumoral activity of the academic CAR-T ARI0002h against normal and low BCMA-expressing myeloma cells after incorporating a transmembrane CD28 domain
Oriol Cardus, Joan Mañé Pujol, Anna de Daniel, et al.
Oncoimmunology
|
July 13, 2025
TIGIT blockade in the context of BCMA-CART cell therapy does not augment efficacy in a multiple myeloma mouse model
Aina Oliver-Caldes, Joan Mañe Pujol, Anthony M Battram, et al.
Journal for Immunotherapy of Cancer
|
December 8, 2021
First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma
Aina Oliver-Caldes, Raquel Jiménez, Marta Español-Rego, et al.
Science Translational Medicine
|
February 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo
Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas, et al.
Page
of 1